Larvol Delta - Strong-impact-of-MammaPrint-and-BluePrint-on-treatment-decisions-in-luminal-early-breast-cancer-results-of-the-WSGPRIMe-study

Mammaprint (ivdmia gene expression breast cancer assay) - Agendia

http://www.ncbi.nlm.nih.gov/pubmed/30796651

Feb 24, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next